Allakos Inc. financial data

Symbol
ALLK on Nasdaq
Industry
Pharmaceutical Preparations
Location
825 Industrial Road, Suite 500, San Carlos, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 511 % -51.8%
Debt-to-equity 49 % +105%
Return On Equity -143 % -180%
Return On Assets -95.7 % -133%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 88.9M shares +2.22%
Common Stock, Shares, Outstanding 88.9M shares +2.34%
Entity Public Float 288M USD +138%
Common Stock, Value, Issued 89K USD +2.3%
Weighted Average Number of Shares Outstanding, Basic 88.6M shares +2.31%
Weighted Average Number of Shares Outstanding, Diluted 88.6M shares +2.31%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 145M USD +26.8%
General and Administrative Expense 42.8M USD -7.74%
Operating Income (Loss) -215M USD -33.9%
Net Income (Loss) Attributable to Parent -206M USD -36.1%
Earnings Per Share, Basic -2.35 USD/shares -61%
Earnings Per Share, Diluted -2.35 USD/shares -61%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 26.5M USD -60.7%
Marketable Securities, Current 96.6M USD -37.1%
Cash, Cash Equivalents, and Short-term Investments 123M USD -44.3%
Assets, Current 128M USD -49.1%
Property, Plant and Equipment, Net 16.6M USD -54.5%
Operating Lease, Right-of-Use Asset 10.2M USD -58.2%
Other Assets, Noncurrent 1.71M USD -74.4%
Assets 156M USD -51%
Accounts Payable, Current 16.1M USD +274%
Employee-related Liabilities, Current 5.67M USD
Accrued Liabilities, Current 19.8M USD -2.06%
Liabilities, Current 35.9M USD +46.5%
Operating Lease, Liability, Noncurrent 36.6M USD -7.94%
Liabilities 72.5M USD +12.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 9K USD
Retained Earnings (Accumulated Deficit) -1.22B USD -20.4%
Stockholders' Equity Attributable to Parent 84M USD -67.1%
Liabilities and Equity 156M USD -51%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -32.5M USD -7.97%
Net Cash Provided by (Used in) Financing Activities 132K USD -90.9%
Net Cash Provided by (Used in) Investing Activities 9.03M USD -74.4%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 88.9M shares +2.34%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -23.4M USD -452%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 28M USD -59.4%
Deferred Tax Assets, Valuation Allowance 374M USD +13.8%
Deferred Tax Assets, Gross 381M USD +12.9%
Operating Lease, Liability 39.7M USD -6.24%
Payments to Acquire Property, Plant, and Equipment 4K USD -98.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -206M USD -36.1%
Lessee, Operating Lease, Liability, to be Paid 57.9M USD -10.7%
Property, Plant and Equipment, Gross 25.1M USD -47.4%
Operating Lease, Liability, Current 3.16M USD +19.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.51M USD +3.01%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.29M USD +3%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 18.2M USD -19.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.73M USD +3%
Deferred Tax Assets, Operating Loss Carryforwards 247M USD +9.42%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 15M USD +13.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 7.96M USD +3%
Operating Lease, Payments 1.8M USD +5.88%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 5.09M USD -16.2%
Deferred Tax Assets, Net of Valuation Allowance 6.59M USD -23.7%
Share-based Payment Arrangement, Expense 33.7M USD -16.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%